In the past 12–18 months, the Single Use Negative Pressure Wound Therapy (NPWT) System industry trends have been shaped by a wave of strategic moves and regulatory shifts.
•Partnerships: MedTech giant 3M entered a distribution alliance with Swedish startup LivaNova to co‑market its new single‑use NPWT platform across North America and Europe, expanding reach into ambulatory surgery centers.
•Mergers & acquisitions: In Q2 2023, Smith & Nephew acquired the U.S.-based single‑use NPWT specialist Avelle for $210 million, integrating Avelle’s patented micro‑pump technology into its wound‑care portfolio.
•Product launches: Cardinal Health introduced the “FlexiSeal” system, featuring a Bluetooth‑enabled pressure sensor that streams real‑time data to clinicians’ mobile apps, addressing demand for remote monitoring.
•Regulatory changes: The FDA’s 2023 revision of the Class II Special Controls for NPWT devices added mandatory cybersecurity standards, prompting manufacturers to certify firmware updates.
•Shift in enterprise trends: Post‑COVID outpatient care growth has driven hospitals to adopt disposable NPWT kits, reducing infection risk and inventory costs.
•Funding & expansion: Berlin‑based startup WoundX secured €45 million Series B funding to scale a low‑cost, recyclable single‑use NPWT unit for emerging markets.
